Children's Oncology Group's 2023 blueprint for research
- PMID: 37433635
- PMCID: PMC10529891
- DOI: 10.1002/pbc.30569
Children's Oncology Group's 2023 blueprint for research
Keywords: biospecimen; cancer; clinical trial; disparities; outcome; pediatric.
References
-
- Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996;88(12):812–816. - PubMed
-
- Lund MJ, Eliason MT, Haight AE, Ward KC, Young JL, Pentz RD. Racial/ethnic diversity in children’s oncology clinical trials: ten years later. Cancer. 2009;115(16):3808–3816. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 CA196173/CA/NCI NIH HHS/United States
- UG1CA233249/NH/NIH HHS/United States
- U10CA098543/NH/NIH HHS/United States
- UM1 CA228823/CA/NCI NIH HHS/United States
- UM1CA228823/NH/NIH HHS/United States
- UM1CA097452/NH/NIH HHS/United States
- UG1 CA189955/CA/NCI NIH HHS/United States
- U10 CA098543/CA/NCI NIH HHS/United States
- U10CA180884/NH/NIH HHS/United States
- U10 CA180899/CA/NCI NIH HHS/United States
- UG1 CA233249/CA/NCI NIH HHS/United States
- UM1 CA097452/CA/NCI NIH HHS/United States
- U24CA114766/NH/NIH HHS/United States
- UG1CA189955/NH/NIH HHS/United States
- U10 CA098413/CA/NCI NIH HHS/United States
- U10CA180886/NH/NIH HHS/United States
- U10 CA095861/CA/NCI NIH HHS/United States
- U24 CA114766/CA/NCI NIH HHS/United States
- U10 CA180884/CA/NCI NIH HHS/United States
- U24CA196173/NH/NIH HHS/United States
- U10CA098413/NH/NIH HHS/United States
- U10CA095861/NH/NIH HHS/United States
- U10 CA180886/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
